The first is based only on people who stayed on treatment
While the 46% proteinuria reduction data positions atacicept with the potential to redefine care, the nephrology field eagerly awaits the final 2027 readout to confirm its definitive role in preserving long-term kidney function
While GLP-1 based therapies are highly effective at managing weight reduction, gastrointestinal (GI) side effects, including nausea (2544 %), diarrhea (1932 %), vomiting (825 %), constipation (1223 %) and abdominal pain (510 %), were common in pivotal Phase 3 studies, although generally transient in nature [[40], [41], [42],46]
It is available as 3, 7 and 14 mg oral tablet formulations
Retatrutide vs semaglutide vs tirzepatide: a heart rate comparison Comparing cardiovascular effects across these three compounds helps put retatrutide heart rate data into context